At ENDO 2026 , taking place June 13 – 16 in Chicago, “Beyond Basic DXA” is set to challenge how clinicians think about bone health assessment. Angela M.
Cheung, MD, PhD, a professor of medicine at the University Health Network and the University of Toronto, will lead “Beyond Basic DXA” on Day 4 (Monday, June 15), a session designed for bone and mineral metabolism specialists ready to move past standard bone density measurements. Her presentation will explore how dual-energy X-ray absorptiometry (DXA) can be expanded with advanced tools such as trabecular bone score (TBS), offering deeper insight into fracture risk, body composition, and early metabolic bone disease.
Cheung’s research interests are in metabolic bone disease, atypical femoral fractures and rare bone diseases. She obtained her MD degree from Johns Hopkins University School of Medicine and her PhD degree from Harvard University.
Endocrine News published a clinical update in Research Highlights on 14 May 2026.
The item focuses on ENDO 2026 Preview: Beyond Basic DXA.
Review the original article for the full source wording and details.